Beacon Biosignals News and Activities

Acquisition, funding and merger involving Beacon Biosignals.

• Beacon Biosignals has just announced a $97 Million fundraising (posted on April 7 2026).

View the org chart displaying its 19 main executives

Most searched biographies at Beacon Biosignals

• Jacob Donoghue, Chief Executive Officer
• Caitlin Donovan, Director
• Naveen Rao, Director

Create your alert
to follow the executive moves at Beacon Biosignals.

Beacon Biosignals has 2,414 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
• Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).
• Osanni Bio has just announced a $190 Million fundraising (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Beacon Biosignals

• FDA Authorizes Beacon’s Dreem 3S as First Sleep Wearable with Predetermined Change Control Plan, Paving the Way for Continuous Algorithm Enhancements in Sleep Monitoring
• Beacon Launches HEADFIRST Clinical Trial to Study Sleep EEG in Pediatric Developmental Disorders, Partners with LGS Foundation
• Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity
• Beacon Biosignals Selected by Longboard Pharmaceuticals to Advance Understanding of Epilepsy and Related Conditions
• Beacon Biosignals and Takeda Launch Strategic Collaboration to Advance Neurobiomarkers and Endpoints for Sleep Disorders
• Beacon Biosignals Expands Sleep Analysis Capabilities with FDA Clearance of SleepStageML
• Dr. Sudhir Sivakumaran Joins Beacon Biosignals as Vice President of Translational Medicine
• Beacon Biosignals welcomes David Matthews, PhD, as Chief Business Officer
• Gate Neurosciences Announces Clinical Collaboration with Beacon Biosignals to Advance Precision EEG Biomarkers in Major Depressive Disorder
• Beacon Biosignals Elevates Brain Health Understanding at AES 2023
• View more press releases Close

Social media about Beacon Biosignals

• Beacon Biosignals on Wikipedia, Google News & Yahoo Finance
• Beacon Biosignals on LinkedIn, X (Twitter) & YouTube